(A) Neonatal testing conducted pursuant to § 44-37-30 must include testing for the following:

(1) Krabbe disease;

(2) Pompe disease; and

(3) Hurler syndrome.

(B) The department shall require additional lysosomal storage disorders to be tested upon the recommendations of the Newborn Screening Advisory Committee and in accordance with § 44-37-30 pursuant to a duly promulgated regulation as testing for such disorders becomes available.